Invention Grant
- Patent Title: CGRP antibodies
- Patent Title (中): CGRP抗体
-
Application No.: US13154538Application Date: 2011-06-07
-
Publication No.: US09073991B2Publication Date: 2015-07-07
- Inventor: Barrett Allan , Robert Jan Benschop , Mark Geoffrey Chambers , Ryan James Darling
- Applicant: Barrett Allan , Robert Jan Benschop , Mark Geoffrey Chambers , Ryan James Darling
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Sanjay Jivraj; Alejandro Martinez
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/00 ; C12P21/08 ; C07K16/26
Abstract:
The present invention provides human engineered calcitonin gene related peptide (CGRP) antibodies or antigen-binding fragment thereof. In addition, the present invention provides the use of the human engineered calcitonin gene related peptide (CGRP) antibodies or antigen-binding fragment thereof for the treatment of osteoarthritis pain.
Public/Granted literature
- US20110305711A1 CGRP ANTIBODIES Public/Granted day:2011-12-15
Information query
